Neumora Therapeutics
NMRA
NMRA
88 hedge funds and large institutions have $725M invested in Neumora Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $745M → $725M (-$20M)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
83% less call options, than puts
Call options by funds: $75K | Put options by funds: $453K
Holders
88
Holding in Top 10
4
Calls
$75K
Puts
$453K
Top Buyers
| 1 | +$49.3M | |
| 2 | +$15.3M | |
| 3 | +$13.8M | |
| 4 |
SCM
Soros Capital Management
New York
|
+$12.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.4M |
Top Sellers
| 1 | -$29M | |
| 2 | -$6.9M | |
| 3 | -$5.91M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$2.62M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$2.4M |